Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 18,263,000 | 17,133,000 | 377,000 | 14,526,000 | 12,358,000 |
| Depreciation Amortization | 5,838,000 | 4,499,000 | 3,872,000 | 3,909,000 | 3,214,000 |
| Income taxes - deferred | -1,671,000 | -1,249,000 | -1,899,000 | -1,568,000 | 187,000 |
| Accounts receivable | -1,090,000 | -244,000 | -1,148,000 | -644,000 | -2,033,000 |
| Accounts payable and accrued liabilities | 110,000 | 182,000 | -380,000 | -289,000 | 405,000 |
| Other Working Capital | -6,976,000 | -3,667,000 | -2,205,000 | -2,782,000 | -3,839,000 |
| Other Operating Activity | 1,998,000 | 4,814,000 | 14,389,000 | 5,943,000 | 2,830,000 |
| Operating Cash Flow | $16,472,000 | $21,468,000 | $13,006,000 | $19,095,000 | $13,122,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 471,000 | -142,000 | 703,000 | -483,000 | 1,025,000 |
| PPE Investments | -4,112,000 | -3,372,000 | -3,863,000 | -4,388,000 | -4,448,000 |
| Net Acquisitions | -10,042,000 | -4,093,000 | -12,032,000 | N/A | -12,907,000 |
| Sale Of Investment | N/A | N/A | 1,145,000 | N/A | N/A |
| Other Investing Activity | -58,000 | -127,000 | -36,000 | -89,000 | -91,000 |
| Investing Cash Flow | $-13,741,000 | $-7,734,000 | $-14,083,000 | $-4,960,000 | $-16,421,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | -3,986,000 |
| Debt Issued | 13,880,000 | 3,599,000 | 5,939,000 | N/A | 7,936,000 |
| Debt Repayment | -2,503,000 | -1,290,000 | -1,755,000 | -2,251,000 | -2,319,000 |
| Common Stock Issued | 92,000 | 177,000 | 125,000 | 384,000 | 202,000 |
| Common Stock Repurchased | -5,084,000 | -1,306,000 | -1,346,000 | N/A | -840,000 |
| Dividend Paid | -8,176,000 | -7,840,000 | -7,445,000 | -7,012,000 | -6,610,000 |
| Other Financing Activity | -131,000 | -372,000 | -328,000 | -240,000 | 8,714,000 |
| Financing Cash Flow | $-1,922,000 | $-7,032,000 | $-4,810,000 | $-9,119,000 | $3,097,000 |
| Exchange Rate Effect | 563,000 | -293,000 | 23,000 | -410,000 | -133,000 |
| Beginning Cash Position | 13,318,000 | 6,909,000 | 12,773,000 | 8,167,000 | 8,153,000 |
| End Cash Position | 14,690,000 | 13,318,000 | 6,909,000 | 12,773,000 | 8,167,000 |
| Net Cash Flow | $1,372,000 | $6,409,000 | $-5,864,000 | $4,606,000 | $14,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 16,472,000 | 21,468,000 | 13,006,000 | 19,095,000 | 13,122,000 |
| Capital Expenditure | -4,112,000 | -3,372,000 | -3,863,000 | -4,388,000 | -4,448,000 |
| Free Cash Flow | 12,360,000 | 18,096,000 | 9,143,000 | 14,707,000 | 8,674,000 |